Experts approve Sputnik V, third vaccine for India
New York, April 13 -- Russia's Covid vaccine Sputnik V has been recommended for use in India by a committee of experts as the country battles a record spike in virus cases in the country. If approved by regulator DCGI, this will be the third vaccine to be used in India after Serum Institute of India'sCovishield- developed by Oxford-AstraZeneca - and Bharat Biotech'sCovaxin.
Sputnik V,manufactured in India by Dr Reddy's, has the highest effectiveness - 91.6 per cent - after the Moderna and Pfizer shots. Dr Reddy's had applied on February 19 for emergency use of the vaccine, which is in Phase 3 of clinical trials in India.
After the Subject Expert Committee (SEC)'s recommendation, the vaccine has to be greenlit by the Drug Controller Gene...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.